Related Experiment Video
Updated: May 5, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
34.4K
Asthma mortality in France
The Journal of Allergy and Clinical Immunology
|September 1, 1987
Summary
Asthma mortality trends show initial decreases followed by increases in France. Specific immunotherapy and "corticophobia" may contribute to deaths in asthma patients.
Area of Science:
- Pulmonology
- Epidemiology
- Public Health
Background:
- Asthma mortality was historically underestimated in France, contrary to recognition in other Western countries.
- The absence of an observed asthma death
- epidemic
- in the 1960s and subsequent trends in French asthma mortality rates require examination.
Purpose of the Study:
- To analyze trends in asthma mortality in France from 1968 onwards.
- To compare French asthma death rates with those in other European countries, specifically Denmark and Germany.
- To investigate potential contributing factors to asthma mortality, including treatment modalities and patient-reported reasons for death.
Main Methods:
- Analysis of national mortality data for asthma in France.
- Comparative analysis of asthma death rates across different age groups and genders.
- Review of reported causes of death in asthma patients, including iatrogenic causes and alternative medicine use.
Main Results:
- Asthma deaths in France decreased from 1968 until 1974 (females) and 1980 (males), followed by an increase to 2.9/100,000 (males) and 3.6/100,000 (females).
- A slight increase in asthma deaths was observed in the 5-34 age group (0.35/100,000 males, 0.39/100,000 females).
- German asthma death rates in the 5-34 age group were significantly higher than in France and Denmark, with a notable increase observed.
Conclusions:
- Asthma mortality trends in France exhibit complex patterns, with recent increases noted after initial declines.
- Specific immunotherapy and patient avoidance of corticosteroids (corticophobia), leading to reliance on alternative therapies like homeopathy and acupuncture, are potential contributors to asthma deaths.
- International comparisons highlight significant variations in asthma mortality, underscoring the need for further research into causative factors and effective management strategies.
Related Concept Videos
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-III: Symptoms and Complications
3.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.5K
Asthma-IV: Nursing Management
4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
4.0K
Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49

